Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,896.50down ₹4.60 (0.24%)BSE ₹1,892.15
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.
2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10
52-week range of traded prices to 2 Nov 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,817 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,06,59351.5% delivered
Wockhardt share news and announcements
1,014 announcements, routine notices left out, newest first. Page 16 of 21.
Jul 2013
22 Jul · Updates
In continuation to our Communication dated May 24, 2013, regarding the import alert from the US FDA on the Company's Waluj facility, we wish to communicate that we have received a "warning letter", which lists the observations made during the inspection. The Company has already initiated several corrective actions to resolve the same.Our earlier clarification on the implications of the import alert on the Company's consolidated revenues for the current financial year remain unchanged. If any additional measures are necessary, the Company would take them to squarely address all concerns. The Company continues to cooperate with FDA to resolve the issues at the earliest
May 2013
27 May · Dividend
Board of Directors of the Company at its meeting held on May 27, 2013, inter alia, has transacted the following business:(1) The Board recommended dividend @ 0.01% (Rs. 0.0005 per preference share of Rs. 5/- each) absorbing a sum of Rs. 298,557/- on 475,659,941 Non-Convertible Cumulative Redeemable Preference shares of Rs. 5/- each and 121,454,927 Optionally Convertible Cumulative Redeemable Preference Shares of Rs. 5/- each. The dividend, if declared at the Annual General Meeting, will be paid within 30 days from the date of Annual General Meeting.(2). The Board recommended dividend of Rs. 5/- per equity share of Rs. 5/- each (i.e. @ 100%) on equity shares of the Company for the year 2012-2013. The dividend, if declared at the Annual General Meeting, will be paid within 30 days from the date of Annual General Meeting.27 May · Board meeting
Board of Directors of the Company at its meeting held on May 27, 2013 has considered appointment of Mr. V. Suresh as "President - Finance" of the Company.24 May · Updates
Company has received an 'import alert' from USFDA on one of its manufacturing unit located in Waluj near Aurangabad. The impact of the import alert on the revenues is estimated to be in the range of $100m on an annualised basis. The Company is taking all steps to address the concerns raised by USFDA and shall put all efforts to resolve the issue at the earliest.13 May · Board meeting
Inter alia, to consider and approve the following: (1) Approval of the Audited Consolidated and Standalone financial results of the Company for the quarter and year ended March 31, 2013. (2) Recommendation of dividend on preference shares and equity shares. Further the Company has informed that, in the Audit Committee meeting scheduled to be held on, May 27, 2013, the appointment of Mr. V. Suresh as President - Finance will also be considered.
Apr 2013
26 Apr · Updates
Company had issued OCCRPS - 2, which were optionally convertible on or after July 04, 2016 and if not converted were to be redeemed on December 31, 2018. Pursuant to the modification in the terms of the said OCCRPS- 2, the Company has redeemed 116,539,748 OCCRPS -2.
Mar 2013
7 Mar · Disclosure
Compensation Committee of the Board has approved the Grant of 8,500 stock options @ Rs. 5/- per option to Independent Directors of the Company, convertible into 8,500 equity shares of Rs. 5/- each under Wockhardt Employees' Stock Options Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999.
Feb 2013
1 Feb · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2012.
Jan 2013
25 Jan · Business
25,300 equity shares of face value of Rs.5/- each of the company are allotted pursuant to exercise of employee stock options under ESOP Scheme - 2011 of the Company.
Dec 2012
26 Dec · Business
122,200 equity shares of face value of Rs.5/- each of the Company were allotted pursuant to exercise of employee stock options
Nov 2012
30 Nov · Updates
Company had issued 208,555,274 OCCRPS-1, which were optionally convertible on or after October 25, 2015 and if not converted were to be redeemed on December 31, 2018. Pursuant to the modification in the terms of the said OCCRPS-1, the Company has redeemed the entire 208,555,274 OCCRPS-1 on November 27, 2012.2 Nov · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2012.
Sep 2012
24 Sep · Updates
Winding-up petition filed by the Trustees to the Foreign Currency Convertible Bonds before the Hon'ble Bombay High Court has been withdrawn.
Aug 2012
6 Aug · Meeting
Annual General Meeting of the Company will be held on September 13, 2012. Further, the Register of Members and Share Transfer Books of the Company shall remain closed from September 05, 2012 to September 13, 2012(both days inclusive) for the purpose of Annual General Meeting of the Company and declaration of Preference dividend.
Jul 2012
27 Jul · Updates
Company had entered into an agreement with Danone for divestment of its Nutrition Business. The Company on July 26, 2012 has closed the said transaction for a consideration of Rs.1,280 crores, including its wholly owned subsidiary.23 Jul · Board meeting
Inter alia , to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2012.
Jun 2012
27 Jun · Disclosure
Compensation Committee of the Board, has approved the Grant of 3,50,000 Stock Options @ Rs. 5/- per option convertible into 3,50,000 equity shares of Rs. 5/- each under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock purchase Scheme) Guidelines, 1999.25 Jun · Demise of Director
Dr. Abid Hussain, Non-Executive and Independent Director of the Company passed away on June 21, 2012. The Board places on record its appreciation for the valuable guidance and contribution to the board made by him during his tenure as a Director of the Company and extends its deepest condolence to his family.
May 2012
22 May · Dividend
Board of Directors of the Company at its meeting held May 22, 2012 has recommended dividend @ 0.01% (Rs. 0.0005 per preference share of Rs. 5/- each) absorbing a sum of Rs.21,75,171/- and dividend distribution tax of Rs. 3,52,867/-, on cumulative basis, on 107,61,98,988 Non- Convertible Cumulative Redeemable Preference shares of Rs. 5/- each and 44,65,49,949 Optionally Convertible Cumulative Redeemable Preference Share of Rs. 5/- each out of the net profits of the Company as per the provisions of section 205 of the Companies Act, 1956. The dividend, if declared at the Annual General Meeting, will be paid within 30 days from the date of Annual General Meeting.10 May · Board meeting
Inter alia, to consider and approve the audited financial results of the Company for the quarter and year ended March 31, 2012.2 May · Results
Company will submit Audited Financial Results for the Financial Year ended March 31, 2012 on or before May 30, 2012 and hence the unaudited financial results for the last quarter ended March 31, 2012 will not be submitted to the Exchange.
Apr 2012
Feb 2012
2 Feb · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2011.
Jan 2012
Nov 2011
18 Nov · Board meeting
Compensation Committee of the Board at its meeting held on November 12, 2011, inter alia, has approved the Grant of 1,540,000 Stock Options convertible into 1,540,000 equity shares of Rs. 5/- each (60,000 options @ Rs. 397/- per option; 60,000 options @ Rs. 365/- per option; 1,420,000 options @ Rs. 5/- per option) under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, to the selected employees of the Company and its subsidiaries.12 Nov · Disclosure
Compensation Committee of the Board at its meeting held on November 12, 2011 has approved the Grant of 1,540,000 Stock Options convertible into 1,540,000 equity shares of Rs. 5/- each (60,000 options @ Rs.397/- per option; 60,000 options @ Rs.365/- per option; 1,420,000 options @ Rs. 5/- per option) under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, to the selected employees of the Company and its subsidiaries.3 Nov · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2011.
Sep 2011